ClavystBio
ClavystBio and A*STAR partner to grow MedTech ventures in Singapore
ClavystBio, a life sciences investor and venture builder established by Temasek, and the Agency for Science, Technology and Research (A*STAR), Singapore's lead public sector research and development (R&D) agency, have signed a memorandum of understanding (MoU) to create and grow MedTech ventures in Singapore.
June 11, 2025
Elice shares fall in KOSDAQ debut after $151M IPO
October 20, 2026
Neolix raises nearly $400M Series E led by Boyu
October 20, 2026
Elice shares fall in KOSDAQ debut after $151M IPO
October 20, 2026
Neolix raises nearly $400M Series E led by Boyu
October 20, 2026




